Literature DB >> 25592480

Dose-dependent neuroprotection of delta-opioid peptide [D-Ala(2), D-Leu(5)] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into the abdominal aorta in rabbits.

Haitong Liu1, Binbin Chen1, Shitong Li1, Junyan Yao2.   

Abstract

OBJECTIVE: In our prior study, we showed that delta-opioid peptide [D-Ala(2), D-Leu(5)] enkephalin (DADLE), by regional perfusion into the abdominal aorta, could protect the spinal cord against ischemia-reperfusion (I/R) injury caused by aortic occlusion. However, the relative dose-response effects of DADLE still remain unclear. This study investigated whether DADLE has a dose-dependent efficiency on spinal cord I/R injury.
METHODS: New Zealand White rabbits were randomly divided into one of six groups: normal saline (NS; n = 8), DADLE (D) groups D0.0005 (n = 8), D0.005 (n = 8), D0.05 (n = 8), and D0.5 mg/kg (n = 8), and a sham group (n = 6). In the NS and DADLE groups, spinal cord ischemia was induced by infrarenal aortic occlusion for 30 minutes. During the occlusion, the same volume of NS or DADLE at the indicated doses was infused continuously through a catheter to the distally clamped abdominal aorta. Heart rate, blood pressure, and core temperature were monitored continuously to evaluate the potential adverse effects of DADLE. Neurologic behavioral function was assessed with the Tarlov scale system at 1, 6, 24, 48, and 72 hours after reperfusion. Neuronal injury evaluation in the ventral horn of the gray matter was evaluated by counting the normal motor neurons at 72 hours after reperfusion.
RESULTS: The therapeutic benefits increased at the doses of DADLE from 0.0005 to 0.05 mg/kg and decreased at 0.5 mg/kg, whereas the hemodynamic parameter was suppressed temporarily at the dose of 0.5 mg/kg.
CONCLUSIONS: These data revealed that regional administration of DADLE through the abdominal aorta provided dose-dependent protection on spinal cord I/R in rabbits.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592480     DOI: 10.1016/j.jvs.2014.11.074

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

Review 1.  Delta Opioids: Neuroprotective Roles in Preclinical Studies.

Authors:  Shahid Husain
Journal:  J Ocul Pharmacol Ther       Date:  2018 Jan/Feb       Impact factor: 2.671

2.  Protective Effects of UCF-101 on Cerebral Ischemia-Reperfusion (CIR) is Depended on the MAPK/p38/ERK Signaling Pathway.

Authors:  Danying Su; Jing Ma; Zhuobo Zhang; Ye Tian; Baozhong Shen
Journal:  Cell Mol Neurobiol       Date:  2015-10-01       Impact factor: 5.046

3.  Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models.

Authors:  Hamdy Awad; Alexander Efanov; Jayanth Rajan; Andrew Denney; Bradley Gigax; Peter Kobalka; Hesham Kelani; D Michele Basso; John Bozinovski; Esmerina Tili
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-26       Impact factor: 3.685

4.  Effects of D‑Ala2, D‑Leu5‑Enkephalin pre‑ and post‑conditioning in a rabbit model of spinal cord ischemia and reperfusion injury.

Authors:  Danyun Fu; Haitong Liu; Hua Liu; Junyan Yao
Journal:  Mol Med Rep       Date:  2019-10-07       Impact factor: 2.952

5.  Antioxidative and Antiapoptotic Effects of Delta-Opioid Peptide [D-Ala2, D-Leu5] Enkephalin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits.

Authors:  Danyun Fu; Haitong Liu; Shitong Li; Lianhua Chen; Junyan Yao
Journal:  Front Neurosci       Date:  2017-10-31       Impact factor: 4.677

6.  [D-Ala2, D-Leu5] Enkephalin Inhibits TLR4/NF-κB Signaling Pathway and Protects Rat Brains against Focal Ischemia-Reperfusion Injury.

Authors:  Danyun Fu; Haitong Liu; Jiang Zhu; Hongjiao Xu; Junyan Yao
Journal:  Mediators Inflamm       Date:  2021-02-12       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.